Impact of Mepolizumab on Airway Remodelling in Severe Eosinophilic Asthma

被引：0
|
作者：
Taille, C. [1 ]
Hamidi, F. [2 ]
Heddebaut, N. [2 ]
Dupin, C. [1 ]
Le Guen, P. [1 ]
Le Brun, M. [1 ]
Pote, N. [3 ]
Cazes, A. [3 ]
Roy, C. [4 ]
Dupont, A. [4 ]
Letuve, S. [2 ]
机构：
[1] Assistance Publ Hop Paris, Dept Resp Dis, Paris, France
[2] INSERM, UMR1152, Paris, France
[3] Assistance Publ Hop Paris, Dept Pathol, Paris, France
[4] Assistance Publ Hop Paris, Dept Clin Res Biostat & Epidemiol, Paris, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2024年 / 209卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1051
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mepolizumab for the reduction of exacerbations in severe eosinophilic asthma
    Russell, Richard
    Brightling, Christopher
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 607 - 617
  • [22] Asthma Control In Patients With Severe Eosinophilic Asthma Treated With Mepolizumab
    Llanos-Ackert, J. -P.
    Price, R. G.
    Forshag, M.
    Yancey, S.
    Liu, M. C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [23] IMPACT OF WEIGHT ON STEROID REDUCTION IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA TREATED WITH MEPOLIZUMAB
    Katial, R.
    Albers, F.
    Prazma, C.
    Bradford, E.
    Ortega, H.
    Price, R.
    Pouliquen, I.
    Castro, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : E3 - E3
  • [24] Mepolizumab improves activity limitation in severe eosinophilic asthma
    Albers, Frank
    Nelsen, Linda M.
    Bratton, Daniel J.
    Bradford, Eric S.
    Braunstahl, G. J.
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [25] Oscillometry in severe eosinophilic asthma commencing mepolizumab or benralizumab
    Fernando, M.
    Jeffrey, B.
    Tierney, C.
    Seccombe, L.
    Peters, M.
    Farah, C.
    Cottee, A.
    RESPIROLOGY, 2023, 28 : 81 - 81
  • [26] CLINICAL RESPONSE TO MEPOLIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA
    Harvey, E.
    Langton, D.
    Powell, H.
    Gibson, P.
    RESPIROLOGY, 2019, 24 : 42 - 42
  • [27] Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype
    Domvri, Kalliopi
    Tsiouprou, Ioanna
    Bakakos, Petros
    Steiropoulos, Paschalis
    Katsoulis, Konstantinos
    Kostikas, Konstantinos
    Antoniou, Katerina M.
    Papaioannou, Andriana I.
    Rovina, Nikoletta
    Katsaounou, Paraskevi
    Papamitsou, Theodora
    Pastelli, Nicoleta
    Tryfon, Stavros
    Fouka, Evangelia
    Papakosta, Despoina
    Loukides, Stelios
    Porpodis, Konstantinos
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : 425 - 435
  • [28] Secondary loss of response to mepolizumab in severe eosinophilic asthma
    Cormier, Maxime
    Chaboillez, Simone
    Lemiere, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (02): : 736 - 738
  • [29] Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
    Manali Mukherjee
    Hui Fang Lim
    Sruthi Thomas
    Douglas Miller
    Melanie Kjarsgaard
    Bruce Tan
    Roma Sehmi
    Nader Khalidi
    Parameswaran Nair
    Allergy, Asthma & Clinical Immunology, 13
  • [30] Clinical response to mepolizumab in patients with severe eosinophilic asthma
    Harvey, Erin
    Langton, David L.
    Powell, Heather
    Gibson, Peter G.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
12345